Latest Insider Transactions at Immuneering Corp (IMRX)
This section provides a real-time view of insider transactions for Immuneering Corp (IMRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Immuneering Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Immuneering Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2021
|
Biren Amin CFO, TREASURER |
BUY
Open market or private purchase
|
Direct |
4,175
+37.7%
|
$62,625
$15.0 P/Share
|
|
Aug 03
2021
|
Biren Amin CFO, TREASURER |
BUY
Conversion of derivative security
|
Direct |
2,723
+50.0%
|
-
|
|
Aug 03
2021
|
Scott Barrett CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
667
+9.1%
|
$10,005
$15.0 P/Share
|
|
Aug 03
2021
|
Scott Barrett CHIEF MEDICAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
5,996
+50.0%
|
-
|
|
Aug 03
2021
|
Ann E Berman Director |
BUY
Open market or private purchase
|
Direct |
3,500
+50.0%
|
$52,500
$15.0 P/Share
|
|
Aug 03
2021
|
Michael Bookman CHIEF LEGAL OFFICER, SECRETARY |
BUY
Open market or private purchase
|
Direct |
1,402
+50.0%
|
$21,030
$15.0 P/Share
|
|
Aug 03
2021
|
Robert J Carpenter Director |
BUY
Open market or private purchase
|
Direct |
325,000
+22.05%
|
$4,875,000
$15.0 P/Share
|
|
Aug 03
2021
|
Robert J Carpenter Director |
BUY
Conversion of derivative security
|
Direct |
217,173
+20.86%
|
-
|
|
Aug 03
2021
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Open market or private purchase
|
Direct |
1,353
+17.47%
|
$20,295
$15.0 P/Share
|
|
Aug 03
2021
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Conversion of derivative security
|
Direct |
5,040
+50.0%
|
-
|
|
Aug 03
2021
|
Laurie Keating Director |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$105,000
$15.0 P/Share
|
|
Aug 03
2021
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
2,098
+0.08%
|
$31,470
$15.0 P/Share
|
|
Aug 03
2021
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Direct |
49,099
+1.85%
|
-
|
|
Aug 03
2021
|
Peter Feinberg Director |
BUY
Open market or private purchase
|
Indirect |
291,667
+22.93%
|
$4,375,005
$15.0 P/Share
|
|
Aug 03
2021
|
Peter Feinberg Director |
BUY
Conversion of derivative security
|
Indirect |
338,835
+36.78%
|
-
|